← Leaderboards
Babak Razani
Veterans Health Administration
$7,423,270
Attributed
$10,483,161
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2010–25$2.5M$1.9M$1.3M$625K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$10,483,161 · 4
VA$0 · 1
By mechanism
R01$9,894,411 · 3
K08$588,750 · 1
I01$0 · 1
Top collaborators
- Bettina Mittendorfer8 shared
- Joel David Schilling4 shared
Most similar at Veterans Health Administration
Same institution · by research overlap
- Sascha Nilu Goonewardena$783,145
- Jack J Hawiger$18,218,108
- Moti L Kashyap$0
- Kamyar Kalantar-Zadeh$11,734,421
- Alyssa H Hasty$5,411,158
Others in their field
Top investigators on “Signal Transduction”
- Peter B. Gilbert · Fred Hutchinson Cancer Center$148,539,615
- David Heimbrook · Leidos Biomedical Research, Inc.$82,049,940
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$70,290,471
- Garret A Fitzgerald · University Of Pennsylvania$66,142,222
- Michael Barry Kastan · Duke University$64,512,357
- Randall J Bateman · Washington University$62,939,456
Research focus
Signal TransductionIn VitroIn VivoInsightMediatingPathway InteractionsFunctional DisorderLipidsMacrophageCellsPhenotypeAtherosclerosisMorbidity - Disease RateResponseMitochondriaProteinsMortalityMyocardial InfarctionCell PhysiologyOverexpressionCause Of DeathAtherogenesisInflammatoryArterial Fatty Streak
Grant awards (33)
Sensing and Clearance of Damaged Lysosomes in Macrophages and Atherosclerosis$760,737
R01 · FY2025 · HL · contact PI
Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseases$637,553
R01 · FY2025 · DK
Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis$607,392
R01 · FY2025 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2025 · VA · contact PI
Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseases$625,037
R01 · FY2024 · DK
Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis$612,844
R01 · FY2024 · HL · contact PI
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis$397,500
R01 · FY2024 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2024 · VA · contact PI
Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseases$660,519
R01 · FY2023 · DK
Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis$640,741
R01 · FY2023 · HL · contact PI
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis$397,500
R01 · FY2023 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2023 · VA · contact PI
Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis$784,370
R01 · FY2022 · HL · contact PI
Harnessing macrophage lysosomal lipid metabolism in obesity-associated diseases$682,718
R01 · FY2022 · DK
Clearance of macrophage p62-enriched protein aggregates as a therapy for atherosclerosis$393,748
R01 · FY2022 · HL · contact PI
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis$2
R01 · FY2022 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2022 · VA · contact PI
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis$393,750
R01 · FY2021 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2021 · VA · contact PI
Clearance of macrophage p62-enriched protein aggregates as a therapy for Atherosclerosis$393,750
R01 · FY2020 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2020 · VA · contact PI
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS$381,250
R01 · FY2019 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2019 · VA · contact PI
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS$381,250
R01 · FY2018 · HL · contact PI
Harnessing the Autophagy-Lysosomal Biogenesis Response in Macrophages to Treat Atherosclerosis$0
I01 · FY2018 · VA · contact PI
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS$381,250
R01 · FY2017 · HL · contact PI
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS$381,250
R01 · FY2016 · HL · contact PI
THE ROLE OF MACROPHAGE LYSOSOMAL BIOGENESIS IN ATHEROSCLEROSIS$381,250
R01 · FY2015 · HL · contact PI
De Novo Lipogenesis in Myocardial Dysfunction$117,750
K08 · FY2014 · HL · contact PI
De Novo Lipogenesis in Myocardial Dysfunction$117,750
K08 · FY2013 · HL · contact PI
De Novo Lipogenesis in Myocardial Dysfunction$117,750
K08 · FY2012 · HL · contact PI
De Novo Lipogenesis in Myocardial Dysfunction$117,750
K08 · FY2011 · HL · contact PI
De Novo Lipogenesis in Myocardial Dysfunction$117,750
K08 · FY2010 · HL · contact PI